VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Interesting tidbits from agm

<< Previous

Bullboard Posts

Next >>

Comment by Stockwatcher123on Dec 14, 2020 2:58pm

161 Views

Post# 32101649

RE:RE:RE:RE:RE:Interesting tidbits from agm

The issue they are facing is legitimate. Who has the time to acquire and learn a new technology when the hospital is filled with patients with life threatening conditions. And why would VPT spend money on a sales force in this environment. It will be dead money for a few months I am afraid but I am seeing the positive changes are taking place. Just because it went down for the past a few years doesn't mean it will go down to 0. I think that is flaw in your argument.

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading